To conclude, our findings demonstrate that HDAC3 silencing can alleviate ESCC cells malignant properties by upregulating miR-494 to limit TGIF1 expression, the mechanism of which was dependent on the activated TGFβ signaling pathway (Fig. 7). This evidence concerns the gene HDAC3 and esophageal squamous cell carcinoma.